New Developments in Depression and Anxiety Disorders
By Charles B. Nemeroff, MD, PhD
Raising the Expectations of Long-Term Treatment Strategies in Anxiety Disorders
By Martin B. Keller, MD
Can We Distinguish Anxiety From Depression?
By David S. Baldwin, FRCPsych, Dwight L. Evans, MD, Robert M. A. Hirschfeld, MD, and Siegfried Kasper, MD
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
By Johan A. den Boer, MD, Dwight L. Evans, MD, Sing Lee, MD, PhD, and Rafael Salin-Pascual, MD
Algorithms in Clinical Psychiatry: A Stepped Approach Toward the Path to Recovery
By Madhukar Trivedi, MD
Mechanism of Action of Antidepressants
By Francesc Artigas, PhD, David J. Nutt, MD, PhD, and Richard Shelton, MD
Depression in the Elderly
By William M. McDonald, MD, Carl Salzman, MD, and Alan F. Schatzberg, MD
Coping With Somatic Comorbidities: Striving for Complete Recovery
By Christer Allgulander, MD, and Siegfried Kasper, MD
Generalized Anxiety Disorder: Raising the Expectations of Treatment
By Christer Allgulander, MD, and David V. Sheehan, MD, MBA
Long-Term Treatment Strategies in Affective Disorders
Recent Advances in the Neurobiology of Depression
Remission: Today’s Target in the Treatment of Mood and Anxiety Disorders
Intermittent Fluoxetine Dosing in the Treatment of Women With Premenstrual Dysphoria
By Meir Steiner, MD, PhD, FRCPC, Marilyn Korzekwa, MD, FRCPC, John Lamont, MD, MSc, FRCSC, and Annette Wilkins, BA
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
By Lindsay DeVane, PharmD
Efficacy and Tolerability of Controlled-Release Paroxetine
By Robert N. Golden, MD
A Discussion on the Methodologies Used to Evaluate Antidepressants
MODERATOR: Jan A. Fawcett, MD
DISCUSSANTS: Norman Sussman, MD Jeffrey H. Newcorn, MD
Risperidone: Review of Its Therapeutic Utility in Depression
By Joyce E. Myers, MD, and Michael E. Thase, MD